Skip navigation

Items where Author is "Sharief, Mohammed"

Items where Author is "Sharief, Mohammed"

[up] Up a level
Group by: Item Type | Uncontrolled Keywords | No Grouping
central nervous system cytokines lamotrigine multiple sclerosis neurodegeneration neurodegenerative diseases phospholipids polyunsaturated fatty acids structured phospholipids treatment of multiple sclerosis triglycerides use patent
Number of items: 22.

central nervous system

BTG International Ltd. (2011) Treatment of neurodegenerative conditions. JP2011144195.

BTG International Ltd. (2011) Treatment of neurodegenerative conditions. EP2324828 (A1).

cytokines

BTG International Ltd (2009) Structured phospholipids. US2009/0036410 A1.

lamotrigine

BTG International Limited (2004) Treatment of neurodegenerative conditions. US 2004/0229873 Al.

multiple sclerosis

BTG International Ltd. (2011) Treatment of neurodegenerative conditions. JP2011144195.

BTG International Ltd. (2011) Treatment of neurodegenerative conditions. EP2324828 (A1).

BTG International Ltd (2009) Structured phospholipids. US2009/0036410 A1.

BTG International Limited (2008) Treatment of neurodegenerative conditions. GB2442161/B.

BTG International Limited (2004) Treatment of neurodegenerative conditions. US 2004/0229873 Al.

neurodegeneration

BTG International Ltd. (2011) Treatment of neurodegenerative conditions. JP2011144195.

BTG International Ltd. (2011) Treatment of neurodegenerative conditions. EP2324828 (A1).

neurodegenerative diseases

BTG International Limited (2008) Treatment of neurodegenerative conditions. GB2442161/B.

phospholipids

BTG International Limited (2006) Structured phospholipids. WO2006/056783 A2.

polyunsaturated fatty acids

BTG International Ltd (2010) Treatment of neurodegenerative conditions. US2010/0113810 A1.

BTG International Limited (2004) Use of triglyceride oils containing gamma-linolenic residues and linoleic acid residues for the treatment of neurodegenerative disease. WO2004/100943 A1.

structured phospholipids

BTG International Ltd (2009) Structured phospholipids. US2009/0036410 A1.

treatment of multiple sclerosis

BTG International Ltd (2010) Treatment of neurodegenerative conditions. US2010/0113810 A1.

BTG International Limited (2006) Structured phospholipids. WO2006/056783 A2.

BTG International Limited (2005) Treatment of neurodegenerative conditions. WO2005/018632/A1.

BTG International Limited (2004) Use of triglyceride oils containing gamma-linolenic residues and linoleic acid residues for the treatment of neurodegenerative disease. WO2004/100943 A1.

triglycerides

BTG International Limited (2008) Treatment of neurodegenerative conditions. GB2442161/B.

use patent

BTG International Limited (2004) Treatment of neurodegenerative conditions. US 2004/0229873 Al.

This list was generated on Sun Dec 22 13:10:43 2024 UTC.